Potential role of natural killer cell receptor-expressing cells in immunotherapy for leukemia.
Natural killer cell receptor (NKR)-expressing cells have cytolytic activity against leukemic cells, and solid tumor cells escape from T-cell recognition because of the low expression levels of class I HLA molecules in both allogeneic and autologous settings. This characteristic feature of NK cell recognition of target cells in contrast with that of T-cells provides a strategy to overcome tolerance in the tumor-bearing host. Furthermore, inhibitory NKR-expressing cells may have cytolytic activity and immunoregulatory functions. Several methods can be used to expand NKR-expressing cells for adoptive immunotherapy for leukemia and other malignant diseases. We review recent developments in the biology and clinical application of NKR-expressing cells, such as NK cells, lymphokine-activated killer cells, cytokine-induced killer cells, NKT cells, and other NKR-expressing cells.
Tanaka
Junji
J
Hematology and Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. jutanaka@med.hokudai.ac.jp
Asaka
Masahiro
M
Imamura
Masahiro
M
D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007694:Killer Cells, Natural / Q000276:immunology*; D007938:Leukemia / Q000276:immunology* / Q000628:therapy*
J Immunol. 2002 May 15;168(10):4864-70
11994435
Eur J Immunol. 2003 Jul;33(7):2033-43
12884870
Transplantation. 2004 Jul 15;78(1):1-6
15257030
Int J Hematol. 2003 Oct;78(3):188-94
14604276
Br J Haematol. 2003 Jul;122(2):231-9
12846891
J Exp Med. 1998 Mar 2;187(5):813-8
9480992
N Engl J Med. 1998 Oct 22;339(17):1177-85
9780337
Cancer Immunol Immunother. 2003 Sep;52(9):525-34
14627124
Br J Haematol. 1998 Mar;100(4):655-63
9531330
Adv Immunol. 2000;74:181-273
10605607
Cancer Immunol Immunother. 1998 Aug;46(6):318-26
9756416
Eur J Immunol. 2003 Dec;33(12):3439-47
14635054
J Immunol. 2003 Oct 1;171(7):3442-50
14500639
Blood. 2002 Sep 15;100(6):1935-47
12200350
Immunity. 1999 Mar;10(3):281-7
10204484
Clin Cancer Res. 2002 Sep;8(9):2812-9
12231521
Blood. 2003 Aug 1;102(3):814-9
12689936
Nature. 2000 Jan 20;403(6767):325-8
10659853
J Immunol. 2004 Jan 1;172(1):644-50
14688377
Acta Haematol. 2001;105(2):89-91
11408710
Nat Immunol. 2001 Mar;2(3):255-60
11224526
Nature. 1998 Feb 19;391(6669):795-9
9486650
Blood. 2004 Aug 1;104(3):768-74
15073036
Blood. 2004 Feb 15;103(4):1521-6
14504099
Immunity. 1999 May;10(5):585-94
10367904
Hum Immunol. 2002 Mar;63(3):200-10
11872238
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12000-4
8265660
Adv Immunol. 2000;76:1-60
11079097
Science. 1999 Jul 30;285(5428):730-2
10426994
Adv Exp Med Biol. 1998;452:13-8
9889954
Blood. 2001 May 15;97(10):3132-7
11342440
Bone Marrow Transplant. 2000 Aug;26(3):287-90
10967567
Blood. 1998 Nov 1;92(9):3318-27
9787169
Blood. 2004 Jul 1;104(1):170-7
15016654
Int J Hematol. 2003 Jul;78(1):1-6
12894844
Br J Haematol. 2000 Mar;108(4):778-83
10792283
Cancer. 1997 Jul 1;80(1):42-9
9210707
Immunol Rev. 2001 Jun;181:185-92
11513139
Adv Cancer Res. 1995;67:155-95
8571814
Nat Rev Immunol. 2003 Oct;3(10):781-90
14523385
Eur J Immunol. 2001 Apr;31(4):1076-86
11298332
J Clin Immunol. 2002 May;22(3):131-6
12078854
Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11328-33
12167676
Blood. 2004 Apr 15;103(8):3122-30
15070694
Int J Hematol. 2003 Jul;78(1):7-17
12894845
Blood. 2003 Mar 1;101(5):2024-32
12406908
Science. 1997 Nov 28;278(5343):1626-9
9374463
Cancer Immunol Immunother. 2004 Oct;53(10):879-92
15338206
Blood. 2002 Nov 15;100(10):3825-7
12393440
Science. 2002 Mar 15;295(5562):2097-100
11896281
Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8088-92
9223319
Blood. 1999 Jul 1;94(1):333-9
10381530
Nature. 2001 Sep 13;413(6852):165-71
11557981
Blood. 1997 Mar 1;89(5):1818-23
9057668
Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12433-8
8901599
J Immunother. 2001 Jul-Aug;24(4):363-73
11565838
Immunol Rev. 1998 Jun;163:197-215
9700512
J Immunol. 2001 Sep 15;167(6):3129-38
11544298
Br J Haematol. 2002 Jun;117(3):751-4
12028053
J Immunol. 1992 Nov 1;149(9):2945-53
1401923
Immunol Today. 1990 Jul;11(7):237-44
2201309
Blood. 2003 Aug 15;102(4):1389-96
12714493
Science. 1995 Apr 21;268(5209):403-5
7716542
J Clin Oncol. 2004 Mar 15;22(6):1136-51
15020616
Immunity. 2001 Feb;14(2):123-33
11239445
Science. 2002 Oct 25;298(5594):850-4
12242449
Blood. 1996 May 1;87(9):3993-4000
8611732
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10896-901
12960383
Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1172-7
9448304
J Exp Med. 1996 Feb 1;183(2):645-50
8627176
Blood. 1999 Oct 1;94(7):2396-402
10498612
Nature. 2002 Oct 17;419(6908):734-8
12384702
N Engl J Med. 1987 Apr 9;316(15):889-97
3493432
Immunity. 2004 Sep;21(3):357-66
15357947
Science. 1999 Jul 30;285(5428):727-9
10426993
Immunol Rev. 1997 Feb;155:105-17
9059886
Bone Marrow Transplant. 2004 Oct;34(7):595-602
15300228
Nat Med. 2001 Sep;7(9):1052-6
11533710
J Exp Med. 1994 Apr 1;179(4):1285-95
7908323
Hematol J. 2000;1(2):136-44
11920181
J Exp Med. 2000 Dec 4;192(11):1637-44
11104805
Blood. 2004 Apr 15;103(8):3065-72
15070686
Br J Haematol. 2002 Jul;118(1):136-9
12100138
Haematologica. 1992 Mar-Apr;77(2):127-9
1398297
Br J Haematol. 2001 Jul;114(1):11-24
11472339
Nat Med. 2001 Sep;7(9):1057-62
11533711
Immunol Today. 1998 Apr;19(4):153-7
9577090
Br J Haematol. 2002 Jun;117(4):821-7
12060116
Blood. 2001 May 15;97(10):2923-31
11342413
J Immunol. 1998 Jun 1;160(11):5239-45
9605119
Nat Med. 1998 Mar;4(3):328-32
9500607
Blood. 2003 May 1;101(9):3730-40
12511415
Cancer. 1995 Sep 1;76(5):824-32
8625186